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Decreased Mechanical Function of Left Atrium Assessed by Novel
Echocardiographic Techniques in Patients with Suboptimal Blood
Pressure Control
Xiaojing Chen, Zhi Zeng
West China Hospital, Sichuan University
OBJECTIVES Suboptimal blood pressure (BP) control is commonly
observed in patients receiving antihypertensive agents, but it remains
unknown the relationship between uncontrolled BP and early
impairment of left atria (LA) function.
METHODS This study enrolled 276 hypertensive patients who had
been medicated, as well as 42 matched normal controls. The BP of
systolic<140mmHg and diastolic<90mmHg was deﬁned as optimal
(HTgp1, n¼145), otherwise as suboptimal BP control (HTgp2, n¼131).
LA function was assessed by tissue Doppler imaging (TDI) and two-
dimensional speckle tracking free strain, including Peak systolic (VSa),
peak early ventricular diastolic (VEa), late ventricular diastolic (VAa)
velocity, Peak systolic (SSa), peak early ventricular diastolic (SEa), and
late ventricular (SAa) strain.
RESULTS Despite a similar LA empty fraction, both hypertensive
groups had a higher BP reading, a thicker interventricular septum
(IVS) and a larger LA mass index than the control group. The reduction
of VSa, VEa, VAa, SSa, SEa, SAa was also obvious in the 2 groups. When
compared between HTgp1 and HTgp2, the latter showed a further
impaired VEa and SEa. (Table)Parameters Controls HT gp HTgp1 HTgp2HTgp1 vs.
HTgp2Systolic BP, mmHg 12212 13816x 12710y 15012x <0.001
Diastolic BP, mmHg 768 8210x 798 8710x <0.001
IVS thickness, mm 9.00.9 11.51.4x 10.91.2x 12.11.1x <0.001
LA volume index, ml/m2 31.74.8 42.88.0x 41.07.5x 43.18.5x <0.001
LA empty fraction, % 617.0 628.4 637.9 638.9 NS
VSa 3.70.6 3.10.6x 3.10.6x 3.00.6x NS
VEa 4.00.9 2.70.6x 2.80.6x 2.50.6x <0.001
VAa 4.00.8 3.60.7y 3.70.7y 3.60.7x NS
SSa 53.110.1 35.98.0x 36.67.8x 35.18.3x NS
SEa 31.27.6 18.57.1x 19.88.3x 17.25.3x 0.002
SAa 21.85.4 17.64.2x 17.63.9x 17.94.5x NSxP<0.001, yP<0.01,*p<0.05, compared with the control group.
CONCLUSIONS Hypertensive patients are associated with early
impairment of LA myocardial function detected by TDI and free strain
speckle tracking. Furthermore, early impairment of LA function could
be attribute to suboptimal BP control as these patients are associated
with reduced VEa and SEa, therefore, more intensive therapy should be
considered.
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Serum Cystatin C as a Potential Predictor for the Progression
of Prehypertension-to-hypertension
Ruimin Dong, Xing Shui, Xujing Xie, Zhenda Zheng, Suhua Li,
Lin Chen, Jinlai Liu, Jieming Zhu
Department of Cardiology, the Third Afﬁliated Hospital of Sun Yat-sen
University, Guangzhou, China
OBJECTIVES Cystatin C (CysC) is considered to be a risk factor of
cardiovascular diseases. However, the association between CysC and
the progression of prehypertension-to-hypertension is not evaluated
before.
METHODS A total of 463 consecutive patients with prehypertension
were enrolled. Serum CysC levels at baseline were measured via an
immunoturbidimetric technique. Then, all subjects underwent a me-
dian three-year follow-up. The primary endpoint was the progression
of prehypertension-to-hypertension diagnosed by upper-arm blood
pressure monitor. A proportional hazard regression analysis was
implemented to model the interval-censored progression-free sur-
vival time data. Receiver operating characteristic curves (ROC) and
multivariate logistic regression analysis were used to evaluate the
predictive value of serum CysC.
RESULTS At last, a total of 124 prehypertensive patients progressed to
hypertension, with a progression rate of 26.78%. Serum CysC levels
were positively associated with the progression rate (hazard ratio:
1.82, 95% CI: 1.32-1.93). Multivariate logistic regression analysisconsidered that increased baseline serum CysC level [OR:1.385 (1.052,
2.836), p<0.001] was an independent predictor for the progression of
prehypertension-to-hypertension. ROC analysis showed that the AUC
of serum CysC for predicting the progression of prehypertension-to-
hypertension was 0.824 (95%CI 0.734-0.912), with an optimum cut-off
of 1.18mg/dl.
CONCLUSIONS Serum CysC might serve as a potential predictor for
the progression of prehypertension-to-hypertension.
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Lifestyle Modiﬁcation Combined with Perindopril Therapy on hsCRP and
MIF Serum Levels in Patients with Stage 1 Hypertension: 1-year Follow-up
Zhibin Chen, Hao Tang, Zhenyu Li, Yanbing Liang, Zhongfu Ma
Department of General Internal Medicine, The 1st Afﬁliated Hospital
of Sun Yat-sen University
OBJECTIVES Last year we reported that lifestyle modiﬁcation in pa-
tients with stage 1 hypertension could achieve goal of blood pressure.
Additional perindopril therapy could achieve lower blood pressure
with lower sensitivity C-reactive protein (hsCRP) and macrophage
inhibitory factor (MIF) serum levels. But the difference was slight
which might be associated with the short period of follow-up
(8 weeks). In order to further deﬁne the anti-inﬂammatory effect of
hypotenser treatment on stage 1 hypertension patients, we extended
the follow-up period to 1 year and monitored the above indexes.
METHODS 86 patients were enrolled into the study after signing
informed consent and they were divided into lifestyle modiﬁcation
group (average age 54.17.2yrs) and perindopril therapy group
(average age 56.16.7yrs) by matched pair design. Perindopril therapy
was added in the latter group while both groups received lifestyle
modiﬁcation. Peripheral serum was collected at the time of enroll-
ment, week 4, week 8, week 12, week 24, week 36 and week 48. ELISA
was applied to determine the serum level of hsCRP and MIF. Patients’
ﬁnancial expense on medication was recorded. Data was ﬁnally
analyzed by SPSS 19.0.
RESULTS In the last year’s submission we showed that additional
perindopril therapy led to better blood pressure control, with lower
hsCRP and MIF but the difference was slight at week 4 and 8. After
1 year’s follow-up there were 8 lost cases (9.3%, 5 cases in lifestyle
modiﬁcation group v.s. 3 cases in perindopril therapy group) (P>0.05).
There was still no signiﬁcant difference of blood pressure between
two groups at week 12 and week 24. At week 36 and week 48 peri-
ndopril therapy group showed lower systolic blood pressure (week 36:
110.48.4mmHg v.s. 128.56.9mmHg, week 48: 110.27.2mmHg v.s.
123.04.8mmHg) (both P<0.05). At week 24, 36 and 48, patients in
perindopril therapy group presented lower levels of hsCRP (week 24:
3.100.12mg/L v.s. 3.420.29mg/L, week 36: 2.920.32mg/L v.s.
3.370.17mg/L, week 48: 2.710.12mg/L v.s. 3.310.19mg/L, all
P<0.05) and MIF (week 24: 7.220.39mg/L v.s. 8.010.46mg/L, week
36: 6.880.24mg/L v.s. 7.850.16mg/L, week 48: 6.160.37mg/L v.s.
7.620.25mg/L, all P<0.05). Though it led to lower inﬂammatory
markers, 8 adverse events were reported in perindopril therapy group,
with 5 cases of non-infection correlated cough, 2 cases of orthostatic
hypotension and 1 case of hyperkalemia. Also perindopril therapy
group had signiﬁcantly higher ﬁnancial expense on medication
(1408.5598.30 RMB v.s. 253.2072.50 RMB, P<0.05).
CONCLUSIONS Extended follow-up showed that lifestyle modiﬁca-
tion still improved blood pressure control and lowered inﬂammatory
markers. Additional perindopril therapy could help to further alleviate
inﬂammation status with the price of increased adverse events
and ﬁnancial expense. Personalized therapy was still advised in
those hypertensive patients with high risk factors and high load of
inﬂammation.GW26-e3862
Prevalence of left atrial enlargement and its independent risk factors
in rural Chinese population: An important but ignored condition
Qiaoyun Ou, Yintao Chen, Shasha Yu, Xiaofan Guo, Huijie Zhao,
Zhao Li, Xingang Zhang, Yingxian Sun
Department of Cardiology, The First Hospital of China Medical
University
OBJECTIVES To discuss prevalence of LAE and its independent risk
factors in rural Chinese population.
METHODS This was a study including a total of 10574 subjects (4768
men and 5806 women) aged  35 years. Disease history and
